Working to Eradicate Gynecologic Cancers

Setsuko Kuki Chambers, MD

Director of Women's Cancers
University of Arizona Cancer Center
1515 N. Campbell Ave.
PO Box 245024
Tucson, AZ
USA 85724-5024

Papers:
8 A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)